In such cases, starting an oral GLP-1 medication may reduce hesitation and improve early engagement with therapy
As research continues, GLP-1s are working to become a more widely recognized option for managing perimenopause effectively
Red dots represent significant differences
Best Practices to Reduce Risk of Aspiration During Sedation/Anaesthesia To decrease gastric volume prior to sedation, thereby reducing the risk of aspiration, patients taking GLP-1 agonists either require doses of their medication to be held or to fast for longer periods than the current nil per os (NPO) guidelines
For some, the transition brings calm and confidence
Orforglipron 3 mg, 12 mg, and 36 mg Convenience of daily oral administration Orforglipron, the novel oral GLP-1 receptor agonist by Eli Lilly, offers significant benefits for weight loss through its convenient once-daily pill formulation, eliminating the need for injections commonly associated with similar medications like semaglutide or Wegovy
/assets/images/provider/photos/2775923.jpeg)
